Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

735
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
735
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Molecular Models02:00

Molecular Models

38.5K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.5K
Ligand Binding Sites02:40

Ligand Binding Sites

12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.0K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.0K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving Generalizability in Whole-Cell Antibiotic Discovery Through Active Learning.

bioRxiv : the preprint server for biology·2026
Same author

Unifying p<i>K</i><sub>a</sub> and Protonation Prediction with Sequence-Based Deep Learning.

Journal of chemical information and modeling·2026
Same author

End-to-end molecular structure elucidation from multimodal NMR spectra images using vision transformers.

Chemical science·2026
Same author

A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer.

Current oncology (Toronto, Ont.)·2026
Same author

Development and validation of a machine learning-based predictive model for early outcomes following combined suction-assisted lipectomy and lymphovenous anastomosis in breast cancer-related lymphedema: a retrospective cohort study.

Frontiers in oncology·2026
Same author

Open-Set Anomaly Segmentation in Complex Scenarios.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026

Related Experiment Video

Updated: Jul 12, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

237

Integrated Molecular Modeling and Machine Learning for Drug Design.

Song Xia1, Eric Chen1, Yingkai Zhang1,2,3

  • 1Department of Chemistry, New York University, New York, New York 10003, United States.

Journal of Chemical Theory and Computation
|October 26, 2023
PubMed
Summary

Computational tools integrate molecular modeling and machine learning to accelerate drug discovery. These methods aid in designing modulators, predicting molecular properties, and screening potential drug candidates, reducing development time and cost.

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.2K

Related Experiment Videos

Last Updated: Jul 12, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

237
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.2K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Machine learning in pharmacology

Background:

  • Drug development is a lengthy, iterative process requiring significant investment.
  • Computational approaches are vital for reducing the time and cost of pharmaceutical research and development.
  • Integrating molecular modeling and machine learning offers powerful tools for drug discovery.

Purpose of the Study:

  • To present a perspective on integrating molecular modeling and machine learning for computational drug design.
  • To highlight novel computational tools for targeting protein-protein interactions and screening drug candidates.
  • To demonstrate the application of these tools using a real-world example of an FDA-approved drug.

Main Methods:

  • Pocket-guided rational design using AlphaSpace for protein-protein interaction targets.
  • Delta machine learning scoring functions for protein-ligand docking and virtual screening.
  • Deep learning models for predicting molecular properties based on optimized geometries.

Main Results:

  • Development of integrated computational tools for modulator design.
  • Successful application of AlphaSpace for targeting protein-protein interactions.
  • Implementation of advanced machine learning and deep learning models for property prediction and screening.

Conclusions:

  • Integrated computational approaches significantly enhance the efficiency of drug discovery and development.
  • These tools offer promising directions for future therapeutic design.
  • The presented methods were validated using the kinase inhibitor Erlotinib, an FDA-approved drug.